Nykaa Share Price: Hot Stocks: Brokerage on Tech Mahindra, Sun Pharma, and Nykaa | Tech US News

[ad_1]

Global brokerage firm Macquarie maintained an outperform rating, Morgan Stanley maintained an overweight rating and BofA upgraded to buy.

We have collected a list of top brokerage firm recommendations from ETNow and other sources:


Macquarie on Tech Mahindra: Outperform | Target 1230 Rs


Macquarie maintained an Outperform rating on Tech Mahindra with a target price of Rs 1230.

Another brokerage firm BofA maintained a buy call on Tech Mahindra with a target of Rs 1180. The closing of the deal needs to be seen in the coming quarters, the brokerage said.

Margins were largely inline in Q2. It added that operating leverage is key to growth in H2.

Morgan Stanley on Sun Pharma: Overweight | Target 1150 Rs

Morgan Stanley maintains Overweight rating on Sun Pharma with a target price of Rs 1150. It reported a strong Q2 of FY23, the brokerage said.

BofA on Nykaa: Buy | Target 1555 Rs

BofA upgraded Nykaa to Buy with a target price of Rs 1555. Buffa said the company is well positioned to maintain revenue growth and margin improvement.

The company reported a strong EBITDA beat. The stock has underperformed recently, the brokerage added, but the company has solid fundamentals, and excellent performance.

(Disclaimer: Recommendations, advice, opinions and views given by experts are their own. They do not represent the views of Economic Times)

[ad_2]

Source link

Please disable your adblocker or whitelist this site!